Literature DB >> 31627209

Curtailing PCOS.

Selma Feldman Witchel1, Helena J Teede2,3, Alexia S Peña4.   

Abstract

Polycystic ovary syndrome (PCOS), characterized by hormonal imbalance and ovarian dysfunction, often starts during adolescence. Inconsistent diagnostic criteria, variable provider knowledge, and lack of consensus pose specific challenges for the care of women with PCOS. These factors encourage inaccurate diagnosis with both under and overdiagnosis. This unfavorable diagnostic experience exasperates affected women and limits timely opportunities for intervention to minimize associated comorbidities, especially during the transition from pediatric to adult care. Recognition of these issues in the care of adolescents and women with PCOS inspired the development of the International Evidence-Based PCOS Guidelines, which emphasize the prevention, screening, and treatment of PCOS across the reproductive lifespan. The Guidelines and accompanying meta-analyses focus on three major categories of associated comorbidities: (1) reproductive; (2) metabolic; and (3) psychological. With the exception of infertility, this article considers common manifestations and comorbidities associated with PCOS throughout the lifecycle. Healthy lifestyle interventions with prevention of excess weight gain comprise the primary intervention for all comorbidities. Hence, early identification of girls "at risk" for PCOS and those with PCOS is a priority. Extensive guidelines for provider and patient education aim to decrease the medical, psychosocial, and economic burdens attributable to PCOS and its associated comorbidities.

Entities:  

Mesh:

Year:  2019        PMID: 31627209     DOI: 10.1038/s41390-019-0615-1

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  96 in total

1.  Prevalence of polycystic ovary syndrome in adolescents.

Authors:  Shawna B Christensen; Mary Helen Black; Ning Smith; Mayra M Martinez; Steve J Jacobsen; Amy H Porter; Corinna Koebnick
Journal:  Fertil Steril       Date:  2013-06-05       Impact factor: 7.329

2.  Young women's psychological distress after a diagnosis of polycystic ovary syndrome or endometriosis.

Authors:  I J Rowlands; H Teede; J Lucke; A J Dobson; G D Mishra
Journal:  Hum Reprod       Date:  2016-07-13       Impact factor: 6.918

3.  Are young adult women with polycystic ovary syndrome slipping through the healthcare cracks?

Authors:  Anuja Dokras; Selma Feldman Witchel
Journal:  J Clin Endocrinol Metab       Date:  2014-02-25       Impact factor: 5.958

Review 4.  Beyond fertility: polycystic ovary syndrome and long-term health.

Authors:  Laura G Cooney; Anuja Dokras
Journal:  Fertil Steril       Date:  2018-10       Impact factor: 7.329

Review 5.  Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis.

Authors:  Daria Lizneva; Richard Kirubakaran; Kateryna Mykhalchenko; Larisa Suturina; Galina Chernukha; Michael P Diamond; Ricardo Azziz
Journal:  Fertil Steril       Date:  2016-08-13       Impact factor: 7.329

6.  Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome.

Authors:  Melanie Gibson-Helm; Helena Teede; Andrea Dunaif; Anuja Dokras
Journal:  J Clin Endocrinol Metab       Date:  2017-02-01       Impact factor: 5.958

Review 7.  Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.

Authors:  Héctor F Escobar-Morreale
Journal:  Nat Rev Endocrinol       Date:  2018-03-23       Impact factor: 43.330

Review 8.  The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

Authors:  Ricardo Azziz; Enrico Carmina; Didier Dewailly; Evanthia Diamanti-Kandarakis; Héctor F Escobar-Morreale; Walter Futterweit; Onno E Janssen; Richard S Legro; Robert J Norman; Ann E Taylor; Selma F Witchel
Journal:  Fertil Steril       Date:  2008-10-23       Impact factor: 7.329

9.  An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence.

Authors:  Lourdes Ibáñez; Sharon E Oberfield; Selma Witchel; Richard J Auchus; R Jeffrey Chang; Ethel Codner; Preeti Dabadghao; Feyza Darendeliler; Nancy Samir Elbarbary; Alessandra Gambineri; Cecilia Garcia Rudaz; Kathleen M Hoeger; Abel López-Bermejo; Ken Ong; Alexia S Peña; Thomas Reinehr; Nicola Santoro; Manuel Tena-Sempere; Rachel Tao; Bulent O Yildiz; Haya Alkhayyat; Asma Deeb; Dipesalema Joel; Reiko Horikawa; Francis de Zegher; Peter A Lee
Journal:  Horm Res Paediatr       Date:  2017-11-13       Impact factor: 2.852

Review 10.  Polycystic ovary syndrome.

Authors:  Ricardo Azziz; Enrico Carmina; ZiJiang Chen; Andrea Dunaif; Joop S E Laven; Richard S Legro; Daria Lizneva; Barbara Natterson-Horowtiz; Helena J Teede; Bulent O Yildiz
Journal:  Nat Rev Dis Primers       Date:  2016-08-11       Impact factor: 52.329

View more
  14 in total

1.  The effect of hyperandrogenism and obesity on mindfulness and metacognition in adolescents with polycystic ovary syndrome.

Authors:  Ozlem Kara; Nazan Kaymaz; Mehmet Erdem Uzun
Journal:  Arch Womens Ment Health       Date:  2022-09-08       Impact factor: 4.405

2.  Diagnosis delayed: health profile differences between women with undiagnosed polycystic ovary syndrome and those with a clinical diagnosis by age 35 years.

Authors:  Renae C Fernandez; Vivienne M Moore; Alice R Rumbold; Melissa J Whitrow; Jodie C Avery; Michael J Davies
Journal:  Hum Reprod       Date:  2021-07-19       Impact factor: 6.918

3.  Inhibiting Kiss1 Neurons With Kappa Opioid Receptor Agonists to Treat Polycystic Ovary Syndrome and Vasomotor Symptoms.

Authors:  Elizabeth A McCarthy; Daniel Dischino; Caroline Maguire; Silvia Leon; Rajae Talbi; Eugene Cheung; Claudio D Schteingart; Pierre J M Rivière; Susan D Reed; Robert A Steiner; Victor M Navarro
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 6.134

4.  Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017.

Authors:  Jingjing Liu; Qunhong Wu; Yanhua Hao; Mingli Jiao; Xing Wang; Shengchao Jiang; Liyuan Han
Journal:  Hum Reprod       Date:  2021-03-18       Impact factor: 6.918

Review 5.  Life Modifications and PCOS: Old Story But New Tales.

Authors:  Yuanyuan Gu; Guannan Zhou; Fangyue Zhou; Qiongwei Wu; Chengbin Ma; Yi Zhang; Jingxin Ding; Keqin Hua
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-13       Impact factor: 6.055

Review 6.  Diabetes, Polycystic Ovarian Syndrome, Obstructive Sleep Apnea, and Obesity: A Systematic Review and Important Emerging Themes.

Authors:  Zarna Bambhroliya; Joel Sandrugu; Michael Lowe; Oluwasemilore Okunlola; Shafaat Raza; Stephen Osasan; Sudiksha Sethia; Tayyaba Batool; Pousette Hamid
Journal:  Cureus       Date:  2022-06-25

7.  Polycystic ovary syndrome and postpartum depression among Hispanics and non-Hispanics: a population-based study.

Authors:  Adriele D Fugal; Joseph B Stanford; Erica B Johnstone; Kebba Kah; Karen C Schliep
Journal:  AJOG Glob Rep       Date:  2022-07-07

Review 8.  A Narrative Review of Current Understanding of the Pathophysiology of Polycystic Ovary Syndrome: Focus on Plausible Relevance of Vitamin D.

Authors:  Rajeshwari Kalyanaraman; Lubna Pal
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

9.  Autoimmunity to the Follicle-Stimulating Hormone Receptor (FSHR) and Luteinizing Hormone Receptor (LHR) in Polycystic Ovarian Syndrome.

Authors:  Hanna A Schniewind; Lisa-Marie Sattler; Christoph W Haudum; Julia Münzker; Waldemar B Minich; Barbara Obermayer-Pietsch; Lutz Schomburg
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

10.  Three-Dimensional Genome Interactions Identify Potential Adipocyte Metabolism-Associated Gene STON1 and Immune-Correlated Gene FSHR at the rs13405728 Locus in Polycystic Ovary Syndrome.

Authors:  Can-Hui Cao; Ye Wei; Rang Liu; Xin-Ran Lin; Jia-Qi Luo; Qiu-Ju Zhang; Shou-Ren Lin; Lan Geng; Si-Kang Ye; Yu Shi; Xi Xia
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-24       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.